TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > SMARTPHLEX > SMARTTRANSVAL – analytical method transfer software

SMARTTRANSVAL

Software for analytical method transfer

Your focus: analytical method transfer

SMARTTRANSVAL is software that assesses if a method can be transferred from a “sender” lab to one or several “receiver” labs according to the tolerance interval approach.

Benefits

Value for you:

  • Always up-to-date and validated software, accessible from any location
  • Reduces report writing to a couple of minutes instead of days
  • Simple, even for non-statisticians!
  • Best-in-class decision making

Enables you to:

  • Determine if a method can be transferred from a “sender” lab to one or several “receiver” labs according to the tolerance interval approach
  • Generate stand-alone transfer reports on the transfer of quantitative analytical method
  • Assess the risk of being out of specification at the new lab

Our statisticians provide support for any questions concerning the use of the software and the processing of your data.

Features

  • Use of Total Analytical Error (TAE) concept (i.e. combine bias and precision)
  • Up to 5 “receiver” labs analyzed in one report
  • Use of β-expectation Tolerance Interval to manage the risk in routine analysis such as suggested in USP 1210
  • Generate an e-CTD report within minutes, in full compliance with authority expectations (ICH Q2, FDA, ISO, EMA, WHO, USP 1220, USP 1210 and USP 1224)
  • Suitable for GxP use: fully validated according to the GAMP5 guidelines and 21 CFR part 11 compliant
  • Decision-making tool: one graph = one decision
  • Software as a Service (SaaS) application:
    • no installation required: no need to validate the system on site
    • no maintenance costs
    • can be accessed from any location
    • always the latest version available, free of charge

To find out more or request a demonstration

CONTACT US

SMARTTRANSVAL – the details

For a quick overview of how SMARTTRANSVAL works, please check out our demo video >>

Request a Demo
Demo Version
Software Login

Related News

Are my (bio)pharmaceutical assay performances reliable? Only probability of success counts!
Are my (bio)pharmaceutical assay performances reliable? Only probability of success counts!
14th September 2021
PharmaLex Global Statistics and Data Science Team announced as winner by BookAuthority
PharmaLex Global Statistics and Data Science Team announced as winner by BookAuthority
16th August 2021
Log or not log (transform data) that’s the question
Log or not log (transform data) that’s the question
1st July 2021

Related Resources

Thought Leadership

  • Why you never really validate your analytical method unless you use the total error approach (part II: Producer and Consumer risks)
  • Why you never really validate your analytical method unless you use the total error approach (part I: concept)
  • New SAS solutions for Population PK Model
  • Bayesian Power, Assurance and Probability of Success: Reproducibility Issues
  • Bayesian Power, Assurance and Probability of success: A quick who’s who
  • Proposal for a Single Arm Clinical Study in Rare Disease using Bayesian Statistics

Case Studies

  • Data Science long-term support to a global submission dossier
  • Tolerance intervals solution
  • Setting calibration frequency for an IVD
  • Preparing for process characterization activities
  • Setup an Atlassian product (Jira, confluence)
  • Validation of SoftMaxPro
  • Development and Implementation of the Robustness Index
  • Implementing parallelism tests in JMP
  • Continuous Manufacturing: Development, Optimization and Validation
  • Biosimilarity assessment on multiple CQAs
  • Bayesian modelling and prediction of patient recruitment
  • Automatic detection of disease events based on accelerometer data
  • Analytical Method Comparisons
  • Acceptance criteria for Bioassay validation
  • Computer Software Validation for Multinational Pharmaceutical Company

Webinars

  • Bayesian Approaches for Incorporating Natural History Data in Studies of Rare and Pediatric Disease
  • Bayesian Adaptive Approaches in Rare and Pediatric Disease
  • Software Suite for the Life Cycle of Analytical Methods & Bioassays: Gain Trust in your Results
  • Introduction to Bayesian Methodologies in CMC
  • Good Statistical Practices - Discovery to Clinical Research

Video & Animation

  • Using Bayesian Statistics for Clinical Research

Related Services

  • Custom Software Development
  • Lab Tools
  • SMARTENOVAL – analytical method validation software
  • SMARTSEELVA – bioassay validation software
  • SMARTSTABELITY – product stability and shelf-life estimation software
  • SMARTSTATS – statistical report writing
  • Statistical Training
  • Statistics and Data Sciences
  • Statistics Software Login
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
PharmaLexGLOBALPharmaLex@PharmaLexGLOBAL·
24 Jun

Milena Shuytsova-Mircheva and Lisa Pascoe latest blog here https://www.pharmalex.com/sponsors-gear-up-for-a-smoother-process-with-ctis-but-must-first-overcome-key-hurdles/ discusses the benefit of the Clinical Trial Information System (CTIS).

💡 Interested in CTIS? Take the Phlexglobal survey to evaluate your preparation https://www.phlexglobal.com/ctis-survey

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • PharmaLex is dedicated to delivering a comprehensive portfolio while their modular approach allows tailor-made solutions. They acknowledge our feedback, modify their approach and adapt accordingly.

    Top 10 Pharma Company
    President
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.






    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #AskTheExpert #TogetherBEYONDCOVID19





        Select your state:

        .
        You can unsubscribe at any time at data.protection@pharmalex.com

        If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

        #TogetherBEYONDCOVID19

        We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for